Morgan Innovation & Technology Ltd Study to examine the feasibility of establishing a Tele-Health Testing Service for pre eclampsia in ante-natal care

目前，6家医院正在对多达1000名妇女进行salurate的临床研究，这是一种预测装置，可以检测怀孕期间可能发生的先兆子痫。这项临床研究是为了确认在其中一家医院进行的一项试点研究的结果，部分资金由教育及卫生局拨款资助。拨款还包括完成设计、潜在制造和确定进入市场的最佳途径是通过设备的分销还是许可。人们认为，后者可能会确保更快地渗透市场，但最有可能的是外国持牌人。与英国国家医疗服务体系（NHS）合作开展这项研究，确定了进一步的市场替代途径，即提供独特的远程医疗检测服务，公司希望在开展当前工作的同时调查其可行性。

Thereis currently a clinical study being undertaken in 6 hospitals of up to 1000 women forSalurate a predictive device which tests for the condition known as pre-eclampsia which canoccur during pregnancy.The clinical study is to confirm the results of a Pilot Study carried out at one of the hospitalsand is partly funded by a TSB Grant. The grant also covers the completion of the design,potential manufacture and determination of whether the best route to market is throughdistribution or licencing of the device. It was thought probable that the latter would ensurequicker penetration of the market but that a foreign licensee was most likely.Working with the NHS on the study has identified a further alternative route to market that ofoffering a unique telehealth testing service and the Company wishes to investigate itsfeasibility in parallel with the current work.